Nathaniel Chin, MD, discusses the impact of new Alzheimer’s treatments in memory care in a commentary published in the Journal of the American Geriatrics Society.
Researchers are investigating whether the drug leuprolide, which is approved for prostate cancer in men, can be used to treat symptoms of Alzheimer’s disease in women.
The past decade of National Institutes of Health (NIH)-funded Alzheimer’s disease and related dementias research yielded multiple scientific advances. Learn more via the 2023 NIH dementia research scientific progress report.
Sterling Johnson, PhD, was recently recognized by the University of Wisconsin Department of Medicine (DOM) as an Outstanding Senior Faculty Researcher.
Dr. Walaszek chatted with host Jan Miyasaki about what new treatments are available, what the annual event will focus on and how ageism impacts society’s views on aging.
Sterling Johnson, PhD, discussed strategies to prevent Alzheimer’s disease and the research being done by the Wisconsin Registry for Alzheimer’s Prevention (WRAP) on Wisconsin Public Radio (WPR).
Lifestyle and chronic health conditions in middle age, along with a person’s education level, show associations with emerging blood markers of neurodegeneration and Alzheimer's disease.
More than 50 students and faculty from the University of Wisconsin–Madison participated and presented at the 2023 Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands.